Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
However, Novo Nordisk's chief scientific officer has suggested that they are investigating a long-acting GLP-1 drug candidate that would require administration once a year rather than once a week
A reusable container with a lid protects the medicine from food drips, and placing it front and center reminds you to take your weekly dose
Half-Life and Dosing: The "half-life" of a drug is how long it takes for half of it to leave your system
A novel class of incretin-based therapies consisting of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) and dual (GLP1/glucose-dependent insulinotropic polypeptide [GIP]) RAs acts by lowering blood sugar and inducing weight loss
